Jd. Glass et al., IMMUNOCYTOCHEMICAL QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE BRAIN - CORRELATIONS WITH DEMENTIA, Annals of neurology, 38(5), 1995, pp. 755-762
The pathogenesis of human immunodeficiency virus (HIV)-associated deme
ntia is unclear, and the underlying pathological substrate has been a
matter of debate. In a prospectively clinically characterized populati
on of acquired immunodeficiency syndrome (AIDS) patients we investigat
ed the relationship between the clinical syndrome of HIV-associated de
mentia and the presence and relative quantity of immunocytochemical ma
rkers for HIV-1 (gp41 antibody), and for macrophages and microglia (HA
M-56 antibody). Sections from the basal ganglia and frontal lobes from
the brains of 51 patients were studied, and the data were stratified
for severity of dementia (16 nondemented, 12 mildly demented, 23 sever
ely demented), rate of dementia progression, duration of AIDS, use of
antiretrovirals, and several other demographic features. We found a hi
ghly significant correlation between the degree of macrophage staining
and the severity of dementia but only a borderline correlation betwee
n the presence and amount of gp41-positive cells and dementia. Several
nondemented patients showed abundant gp41 immunoreactivity, and some
severely demented showed little to no gp41 immunoreactivity. Other cor
relations with the immunostaining data, including antiretroviral use,
were not significant. We conclude that the presence of macrophages and
microglia is a better correlate with HIV-associated dementia than is
the presence and amount of HIV-infected cells in the:brain. These data
support the concept that the pathogenesis of HIV-associated dementia
is likely due to indirect effects of HIV infection of the brain, possi
bly through the actions of macrophages and microglia.